Angiotensin II: a new therapeutic option for vasodilatory shock

References

• VincentJ-Lde BackerDCirculatory ShockN Engl J Med Overseas Ed20133691817261734
   PubMed Web of Science ®Google Scholar
• de BackerDBistonPDevriendtJComparison of Dopamine and Norepinephrine in the Treatment of ShockN Engl J Med Overseas Ed20103629779789
   PubMed Web of Science ®Google Scholar
• SchmittingerCATorgersenCLucknerGSchröderDCHLorenzIDünserMWAdverse cardiac events during catecholamine vasopressor therapy: a prospective observational studyIntensive Care Med201238695095822527060
   PubMed Web of Science ®Google Scholar
• DünserMWMayrAJUlmerHArginine Vasopressin in Advanced Vasodilatory Shock: A Prospective, Randomized, Controlled StudyCirculation2003107182313231912732600
   PubMed Web of Science ®Google Scholar
• GamperGHavelCArrichJVasopressors for hypotensive shockCochrane Database Syst Rev2016339Cd003709
   Google Scholar
• BusseLWMccurdyMTAliOHallAChenHOstermannMThe effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literatureCritical Care201721132429282149
   PubMed Web of Science ®Google Scholar
• JentzerJCVallabhajosyulaSKhannaAKChawlaLSBusseLWKashaniKBManagement of Refractory Vasodilatory ShockChest Epub201819
   Web of Science ®Google Scholar
• BassiEParkMAzevedoLCPTherapeutic Strategies for High-Dose Vasopressor-Dependent ShockCrit Care Res Pract20132013265470865471024151551
   PubMedGoogle Scholar
• LucknerGDünserMWJochbergerSArginine vasopressin in 316 patients with advanced vasodilatory shockCrit Care Med200533112659266616276194
   PubMed Web of Science ®Google Scholar
• BrownSMLanspaMJJonesJPSurvival After Shock Requiring High-Dose Vasopressor TherapyChest2013143366467122911566
   PubMed Web of Science ®Google Scholar
• LucknerGMayrVDJochbergerSComparison of two dose regimens of arginine vasopressin in advanced vasodilatory shockCrit Care Med200735102280228517944015
   PubMed Web of Science ®Google Scholar
• TorgersenCDünserMWWenzelVComparing two different arginine vasopressin doses in advanced vasodilatory shock: a randomized, controlled, open-label trialIntensive Care Med2010361576519756505
   PubMed Web of Science ®Google Scholar
• BenbenishtyJWeissmanCSprungCLBrodsky-IsraeliMWeissYCharacteristics of patients receiving vasopressorsHeart & Lung: The Journal of Acute and Critical Care201140324725220630594
   PubMed Web of Science ®Google Scholar
• JenkinsCRGomersallCDLeungPJoyntGMOutcome of patients receiving high dose vasopressor therapy: a retrospective cohort studyAnaesth Intensive Care200937228628919400494
   PubMed Web of Science ®Google Scholar
• RhodesAEvansLEAlhazzaniWSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Intensive Care Med201743330437728101605
   PubMed Web of Science ®Google Scholar
• MayrVDDünserMWGreilVCauses of death and determinants of outcome in critically ill patientsCritical Care2006106R15417083735
   PubMed Web of Science ®Google Scholar
• JentzerJCCoonsJCLinkCBSchmidhoferMPharmacotherapy Update on the Use of Vasopressors and Inotropes in the Intensive Care UnitJ Cardiovasc Pharmacol Ther201520324926025432872
   PubMed Web of Science ®Google Scholar
• VincentJLMorenoRTakalaJThe SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care MedicineIntensive Care Med19962277077108844239
   PubMed Web of Science ®Google Scholar
• DünserMWRuokonenEPettiläVAssociation of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trialCritical Care2009136R18119917106
   PubMed Web of Science ®Google Scholar
• DünserMWHasibederWRSympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic StressJ Intensive Care Med200924529331619703817
   PubMedGoogle Scholar
• AndreisDTSingerMCatecholamines for inflammatory shock: a Jekyll-and-Hyde conundrumIntensive Care Med20164291387139726873833
   PubMed Web of Science ®Google Scholar
• AsfarPMezianiFHamelJ-FHigh versus Low Blood-Pressure Target in Patients with Septic ShockN Engl J Med Overseas Ed20143701715831593
   PubMed Web of Science ®Google Scholar
• SviriSHashoulJStavIvan HeerdenPVDoes high-dose vasopressor therapy in medical intensive care patients indicate what we already suspect?J Crit Care201429115716024140297
   PubMed Web of Science ®Google Scholar
• LevyBCollinSSennounNVascular hyporesponsiveness to vasopressors in septic shock: from bench to bedsideIntensive Care Med201036122019202920862451
   PubMed Web of Science ®Google Scholar
• HosseinianLWeinerMLevinMAFischerGWMethylene Blue: Magic Bullet for Vasoplegia?Anesth Analg2016122119420126678471
   PubMed Web of Science ®Google Scholar
• MarikPEPastoresSMAnnaneDRecommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care MedicineCrit Care Med20083661937194918496365
   PubMed Web of Science ®Google Scholar
• ChawlaLSBusseLBrasha-MitchellEIntravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot studyCritical Care201418553425286986
   PubMed Web of Science ®Google Scholar
• RussellJABench-to-bedside review: Vasopressin in the management of septic shockCritical Care2009154226
   Web of Science ®Google Scholar
• WalleyKRHeterogeneity of oxygen delivery impairs oxygen extraction by peripheral tissues: theoryJ Appl Physiol19968128858948872660
   PubMed Web of Science ®Google Scholar
• de BackerDCreteurJDuboisM-JThe effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effectsCrit Care Med200634240340816424721
   PubMed Web of Science ®Google Scholar
• de BackerDCreteurJSilvaEVincentJ-LEffects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: Which is best?Crit Care Med20033161659166712794401
   PubMed Web of Science ®Google Scholar
• AsfarPRussellJATuckermannJRadermacherPSelepressin in Septic Shock: A Step Toward Decatecholaminization?Crit Care Med201644123423626672929
   PubMed Web of Science ®Google Scholar
• ChawlaLSBusseLWBrasha-MitchellEAlotaibiZThe use of angiotensin II in distributive shockCritical Care201620113727230465
   PubMed Web of Science ®Google Scholar
• TumlinJAMuruganRDeaneAMOutcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IICrit Care Med201846694995729509568
   PubMed Web of Science ®Google Scholar
• RussellJAWalleyKRSingerJVasopressin versus Norepinephrine Infusion in Patients with Septic ShockN Engl J Med Overseas Ed20083589877887
   PubMed Web of Science ®Google Scholar
• KhannaAEnglishSWWangXSAngiotensin II for the Treatment of Vasodilatory ShockN Engl J Med Overseas Ed20173775419430
   PubMed Web of Science ®Google Scholar
• RussellJALeeTSingerJBoydJHWalleyKRThe Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial ExperienceCrit Care Med201745694094828333757
   PubMed Web of Science ®Google Scholar
• SzerlipHBihoracAChangSEffect of disease severity on survival in patients receiving angiotensin II for vasodilatory shockCrit Care Med20184613868
   Web of Science ®Google Scholar
• MccurdyMBGongLBoldtMAssociation of angiotensin II dose with all-cause mortality in patients with vasodilatory shockCritical Care201822Suppl 182
   Google Scholar
• BusseLWWangXSChalikondaDMClinical Experience With IV Angiotensin II Administration: A Systematic Review of SafetyCrit Care Med20174581285129428489648
   PubMed Web of Science ®Google Scholar
• FournierDLuftFCBaderMGantenDAndrade-NavarroMAEmergence and evolution of the renin–angiotensin–aldosterone systemJ Mol Med201290549550822527880
   PubMed Web of Science ®Google Scholar
• KuntzAThe evolution of the sympathetic nervous system in vertebratesJ Comp Neurol1911213215236
   Google Scholar
• BenigniACassisPRemuzziGAngiotensin II revisited: new roles in inflammation, immunology and agingEMBO Mol Med20102724725720597104
   PubMed Web of Science ®Google Scholar
• ZhuoJLLiXCXcLNew insights and perspectives on intrarenal renin-angiotensin system: Focus on intracrine/intracellular angiotensin IIPeptides20113271551156521699940
   PubMed Web of Science ®Google Scholar
• RolihCAOberKPThe endocrine response to critical illnessMed Clin North Am19957912112247808093
   PubMed Web of Science ®Google Scholar
• du CheyronDLesageADaubinCRamakersMCharbonneauPHyperreninemic hypoaldosteronism: a possible etiological factor of septic shock-induced acute renal failureIntensive Care Med200329101703170914551679
   PubMed Web of Science ®Google Scholar
• HallABusseLWOstermannMAngiotensin in Critical CareCritical Care20182216929558991
   PubMed Web of Science ®Google Scholar
• SparksMACrowleySDGurleySBMirotsouMCoffmanTMClassical Renin-Angiotensin system in kidney physiologyCompr Physiol2014431201122824944035
   PubMed Web of Science ®Google Scholar
• TimmermansPBWongPCChiuATAngiotensin II receptors and angiotensin II receptor antagonistsPharmacol Rev19934522052518372104
   PubMed Web of Science ®Google Scholar
• KurtzAPfeilschifterJHutterARole of protein kinase C in inhibition of renin release caused by vasoconstrictorsAm J Physiol Cell Physiol19862504C563C571
   Web of Science ®Google Scholar
• MargoliusHSKallikreins and Kinins: Molecular Characteristics and Cellular and Tissue ResponsesDiabetes199645Suppl 1S14S19
   Web of Science ®Google Scholar
• DonoghueMHsiehFBaronasEA Novel Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9Circ Res2000875e1e910969042
   PubMed Web of Science ®Google Scholar
• FerrarioCMBrosnihanKBDizDIAngiotensin-(1-7): a new hormone of the angiotensin systemHypertension1991185_SupplIII126III1331937675
   PubMed Web of Science ®Google Scholar
• PaulMPoyan MehrAKreutzRPhysiology of Local Renin-Angiotensin SystemsPhysiol Rev200686374780316816138
   PubMed Web of Science ®Google Scholar
• ShenoySKLefkowitzRJAngiotensin II-stimulated signaling through G proteins and beta-arrestinSci STKE20052005311cm1416304060
   PubMedGoogle Scholar
• DewireSMViolinJDBiased Ligands for Better Cardiovascular Drugs: Dissecting G-Protein-Coupled Receptor PharmacologyCirc Res2011109220521621737816
   PubMed Web of Science ®Google Scholar
• FelkerGMButlerJCollinsSPHeart failure therapeutics on the basis of a biased ligand of the angiotensin-2 type 1 receptor. Rationale and design of the BLAST-AHF study (Biased Ligand of the Angiotensin Receptor Study in Acute Heart Failure)JACC Heart Failure20153319320125650371
   PubMed Web of Science ®Google Scholar
• FerrarioCMSchiffrinELRole of Mineralocorticoid Receptor Antagonists in Cardiovascular DiseaseCirc Res2015116120621325552697
   PubMed Web of Science ®Google Scholar
• DavissonRLOliverioMICoffmanTMSigmundCDDivergent functions of angiotensin II receptor isoforms in the brainJ Clin Invest2000106110310610880053
   PubMed Web of Science ®Google Scholar
• GeisterferAAPeachMJOwensGKAngiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cellsCirc Res19886247497563280155
   PubMed Web of Science ®Google Scholar
• IntenganHDSchiffrinELVascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosisHypertension2001383 Pt 258158711566935
   PubMed Web of Science ®Google Scholar
• RoigEPerez-VillaFMoralesMClinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failureEur Heart J2000211535710610744
   PubMed Web of Science ®Google Scholar
• van de WalRMAPlokkerHWMLokDJADeterminants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibitionInt J Cardiol2006106336737216337046
   PubMed Web of Science ®Google Scholar
• DoerschugKCDelsingASSchmidtGAAshareARenin-angiotensin system activation correlates with microvascular dysfunction in a prospective cohort study of clinical sepsisCritical Care2010141R2420175923
   PubMed Web of Science ®Google Scholar
• AntonucciEGleesonPJAnnoniFAngiotensin II in Refractory Septic ShockShock201747556056627879559
   PubMed Web of Science ®Google Scholar
• LandryDWOliverJAThe Pathogenesis of Vasodilatory ShockN Engl J Med Overseas Ed20013458588595
   PubMed Web of Science ®Google Scholar
• QuayleJMNelsonMTStandenNBATP-sensitive and inwardly rectifying potassium channels in smooth musclePhysiol Rev1997774116512329354814
   PubMed Web of Science ®Google Scholar
• ZhangWEIChenXHuangLSevere sepsis: Low expression of the renin-angiotensin system is associated with poor prognosisExp Ther Med2014751342134824940436
   PubMed Web of Science ®Google Scholar
• DongLWChangYZTongLJTangJJySTangCSRole of regulatory peptide in pathogenesis of shockScience in China Series B, Chemistry, Life Sciences & Earth Sciences1994372162169
   Google Scholar
• DunnCWHortonJWRole of angiotensin II in neonatal sepsisCirc Shock19934021441508508519
   PubMedGoogle Scholar
• CaseyLKriegerBKohlerJRiceCOparilSSzidonPDecreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: a preliminary reportCrit Care Med1981996516546268354
   PubMed Web of Science ®Google Scholar
• OrfanosSEArmaganidisAGlynosCPulmonary Capillary Endothelium-Bound Angiotensin-Converting Enzyme Activity in Acute Lung InjuryCirculation2000102162011201811034953
   PubMed Web of Science ®Google Scholar
• SchmidtCHöcherlKKurtBMoritzSKurtzABucherMBlockade of multiple but not single cytokines abrogates downregulation of angiotensin II type-I receptors and anticipates septic shockCytokine2010491303819914088
   PubMed Web of Science ®Google Scholar
• BucherMHobbhahnJKurtzANitric oxide-dependent downregulation of angiotensin II type 2 receptors during experimental sepsisCrit Care Med20012991750175511546977
   PubMed Web of Science ®Google Scholar
• BucherMIttnerK-PHobbhahnJTaegerKKurtzADownregulation of Angiotensin II Type 1 Receptors During SepsisHypertension200138217718211509472
   PubMed Web of Science ®Google Scholar
• WolfRLMendlowitzMGitlowSENaftchiNMetabolism of Angiotensin II-I131 in Normotensive and Hypertensive Human SubjectsCirculation196123575475813786291
   PubMed Web of Science ®Google Scholar
• LuqueMMartinPMartellNFernandezCBrosnihanKBFerrarioCMEffects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertensionJ Hypertens19961467998058793704
   PubMed Web of Science ®Google Scholar
• AziziMChatellierGGuyeneT-TMurieta-GeoffroyDMenardJAdditive Effects of Combined Angiotensin-Converting Enzyme Inhibition and Angiotensin II Antagonism on Blood Pressure and Renin Release in Sodium-Depleted NormotensivesCirculation19959248258347641363
   PubMed Web of Science ®Google Scholar
• WunderinkRABusseTDeaneLBaseline angiotensin levels and ACE effects in patients with vasodilatory shock treated with angiotensin IIIntensive Care Medicine Experimental20175Suppl 20703
   Google Scholar
• RosenfeldCRNadenRPUterine and nonuterine vascular responses to angiotensin II in ovine pregnancyAm J Physiol Heart Circ Physiol19892571H17H24
   Web of Science ®Google Scholar
• RaminSMRaminKDCoxKMagnessRRShearerVEGantNFComparison of prophylactic angiotensin II versus ephedrine infusion for prevention of maternal hypotension during spinal anesthesiaAm J Obstet Gynecol199417137347398092223
   PubMed Web of Science ®Google Scholar
• NadenRPRosenfeldCREffect of angiotensin II on uterine and systemic vasculature in pregnant sheepJ Clin Invest19816824684747263862
   PubMed Web of Science ®Google Scholar
• VincentRDWerhanCFNormanPFProphylactic Angiotensin II Infusion during Spinal Anesthesia for Elective Cesarean DeliveryAnesthesiology1998886147514799637639
   PubMed Web of Science ®Google Scholar
• ContiCTranquilliALGarzettiGGRomaniniCModulation of vascular reactivity after acute calcium antagonist administration in pregnant women moderately sensitive to angiotensin infusionBollettino della Societa italiana di biologia sperimentale19947010–112432487702827
   PubMedGoogle Scholar
• ÖneyTKaulhausenHThe value of the angiotensin sensitivity test in the early diagnosis of hypertensive disorders in pregnancyAm J Obstet Gynecol1982142117207055166
   PubMed Web of Science ®Google Scholar
• JacksonTCorkeCAgarJEnalapril overdose treated with angiotensin infusionThe Lancet19933418846703
   Web of Science ®Google Scholar
• NewbyDELeeMRGrayAJBoonNAEnalapril overdose and the corrective effect of intravenous angiotensin II [letter]Br J Clin Pharmacol19954011031048527259
   PubMed Web of Science ®Google Scholar
• TrilliLEJohnsonKALisinopril Overdose and Management with Intravenous Angiotensin IIAnn Pharmacother19942810116511687841571
   PubMed Web of Science ®Google Scholar
• KatoTMurakamiYSaitoYNew modality of radiation therapy under increased tumor oxygen tension with angiotensin II: a pilot studyRadiat Med199311386908372242
   PubMedGoogle Scholar
• SatoHSugiyamaKHoshiMUrushiyamaMIshizukaKAngiotensin II (AII) induced hypertension chemotherapy (IHC) for unresectable gastric cancer: With reference to resection after down stagingWorld J Surg19951968368428553675
   PubMed Web of Science ®Google Scholar
• NagamitsuAGreishKMaedaHElevating blood pressure as a strategy to increase tumor-targeted delivery of macromolecular drug SMANCS: cases of advanced solid tumorsJpn J Clin Oncol2009391175676619596662
   PubMed Web of Science ®Google Scholar
• TomuraNKatoTKannoIIncreased blood flow in human brain tumor after administration of angiotensin II: demonstration by PETComput Med Imaging Graph19931764434498287355
   PubMed Web of Science ®Google Scholar
• MillarEAAngusRMHulksGMortonJJConnellJMThomsonNCActivity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung functionThorax19944954924958016772
   PubMed Web of Science ®Google Scholar
• MillarEANallyJEThomsonNCAngiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivoEur Respir J1995811183818418620948
   PubMed Web of Science ®Google Scholar
• RamsaySGClaytonRADaggKDThomsonLJNallyJEThomsonNCEffect of angiotensin II on histamine-induced bronchoconstriction in the human airway both in vitro and in vivoRespir Med199791106096159488894
   PubMed Web of Science ®Google Scholar
• CohnJNLuriaMHStudies in clinical shock and hypotension. II. Hemodynamic effects of norepinephrine and angiotensinJ Clin Invest19654491494150414332162
   PubMed Web of Science ®Google Scholar
• AmesRPBorkowskiAJSicinskiAMLaraghJHProlonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, and aldosterone and cortisol secretion in normal man and in cirrhosis with ascitesJ Clin Invest19654471171118614328394
   PubMed Web of Science ®Google Scholar
• JoannidisMDrumlWForniLGPrevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017: Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care MedicineIntensive Care Medicine201743673074928577069
   PubMed Web of Science ®Google Scholar
• GaudrySHajageDSchortgenFInitiation strategies for renal-replacement therapy in the intensive care unitN Engl J Med Overseas Ed20163752122133
   PubMed Web of Science ®Google Scholar
• ZarbockAKellumJASchmidtCEffect of early vs delayed initiation of renal replacement therapy on mortality in critically Ill patients with acute kidney injuryJAMA2016315202190219927209269
   PubMed Web of Science ®Google Scholar
• ZarjouAAgarwalASepsis and acute kidney injuryJ Am Soc Nephrol2011226999100621566052
   PubMed Web of Science ®Google Scholar
• LangenbergCBagshawSMMayCNBellomoRThe histopathology of septic acute kidney injury: a systematic reviewCrit Care2008122R3818325092
   PubMed Web of Science ®Google Scholar
• LankadevaYRKosakaJEvansRGBaileySRBellomoRMayCNIntrarenal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injuryKidney Int201690110010827165831
   PubMed Web of Science ®Google Scholar
• ChenHBusseLWNovel therapies for acute kidney injuryKidney Int Rep20172578579929270486
   PubMed Web of Science ®Google Scholar
• SchrierRWWangWPooleBMitraAAcute renal failure: definitions, diagnosis, pathogenesis, and therapyJ Clin Invest2004114151415232604
   PubMed Web of Science ®Google Scholar
• WanLLangenbergCBellomoRMayCNAngiotensin II in experimental hyperdynamic sepsisCrit Care2009136R19019948019
   PubMed Web of Science ®Google Scholar
• Herget-RosenthalSSanerFChawlaLSApproach to hemodynamic shock and vasopressorsClin J Am Soc Nephrol20083254655318256381
   PubMed Web of Science ®Google Scholar
• GordonACMasonAJThirunavukkarasuNEffect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: The VANISH randomized clinical trialJAMA2016316550951827483065
   PubMed Web of Science ®Google Scholar
• AbueloJGNormotensive ischemic acute renal failureN Engl J Med2007357879780517715412
   PubMed Web of Science ®Google Scholar
• ProwleJRBellomoRSepsis-associated acute kidney injury: macrohemodynamic and microhemodynamic alterations in the renal circulationSemin Nephrol2015351647425795500
   PubMed Web of Science ®Google Scholar
• LankadevaYRKosakaJEvansRGBellomoRMayCNUrinary Oxygenation as a Surrogate Measure of Medullary Oxygenation During Angiotensin II Therapy in Septic Acute Kidney InjuryCrit Care Med2018461e41e4829077618
   PubMed Web of Science ®Google Scholar
• BrennerMSchaerGLMalloryDLSuffrediniAFParrilloJEDetection of renal blood flow abnormalities in septic and critically ill patients using a newly designed indwelling thermodilution renal vein catheterChest19909811701792361386
   PubMed Web of Science ®Google Scholar
• ThomasVLNielsenMSAdministration of angiotensin II in refractory septic shockCrit Care Med1991198108410851860334
   PubMed Web of Science ®Google Scholar
• TovarJLBujonsIRuizJCIbañezLSalgadoATreatment of severe combined overdose of calcium antagonists and converting enzyme inhibitors with angiotensin IINephron19977722399346394
   PubMed Web of Science ®Google Scholar
• WrayGMCoakleyJHSevere septic shock unresponsive to noradrenalineLancet1995346899016047500755
   PubMed Web of Science ®Google Scholar
• SuberviolaBRodrigoEGonzález-CastroASerranoMHerasMCastellanos-OrtegaÁAssociation between exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers prior to septic shock and acute kidney injuryMed Intensiva2017411212728341094
   PubMed Web of Science ®Google Scholar
• CorrêaTDTakalaJJakobSMAngiotensin II in septic shockCrit Care2015199825886853
   PubMed Web of Science ®Google Scholar
• UmbrelloMFormentiPBolgiaghiLChiumelloDCurrent Concepts of ARDS: A Narrative ReviewInt J Mol Sci201618164
   PubMed Web of Science ®Google Scholar
• RyanJWProcessing of endogenous polypeptides by the lungsAnnu Rev Physiol1982442412556176181
   PubMed Web of Science ®Google Scholar
• OrfanosSELanglebenDKhouryJPulmonary capillary endothelium-bound angiotensin-converting enzyme activity in humansCirculation199999121593159910096936
   PubMed Web of Science ®Google Scholar
• BusseLAGongTThompsonMOutcomes in patients with acute respiratory distress syndrome receiving angiotensin II for vasodilatory shockCritical Care201822Suppl 182
   Google Scholar
• ARDS Definition Task ForceRanieriVMRubenfeldGDThompsonBTAcute respiratory distress syndrome: the Berlin DefinitionJAMA2012307232526253322797452
   PubMed Web of Science ®Google Scholar
• ImaiYKubaKRaoSAngiotensin-converting enzyme 2 protects from severe acute lung failureNature2005436704711211616001071
   PubMed Web of Science ®Google Scholar
• LambertDWHooperNMTurnerAJAngiotensin-converting enzyme 2 and new insights into the renin-angiotensin systemBiochem Pharmacol200875478178617897633
   PubMed Web of Science ®Google Scholar
• WangGZhangQYuanWWuJLiCEnalapril protects against myocardial ischemia/reperfusion injury in a swine model of cardiac arrest and resuscitationInt J Mol Med20163851463147327633002
   PubMed Web of Science ®Google Scholar
• ArnalJFCudekPPlouinPFGuyenneTTMichelJBCorvolPLow angiotensinogen levels are related to the severity and liver dysfunction of congestive heart failure: implications for renin measurementsAm J Med199190117221824738
   PubMed Web of Science ®Google Scholar
• ImaiMSokabeHPlasma renin and angiotensinogen levels in pathological states associated with oedemaArch Dis Child1968432304754794299072
   PubMed Web of Science ®Google Scholar
• FaymonvilleMELarbuissonRRadermeckerMLimetRFournyJLamyMSerum activity of angiotensin converting enzyme during extra-corporeal circulation in manC R Seances Soc Biol Fil198317722522586309338
   PubMedGoogle Scholar
• PanagiotopoulosIPalatianosGMichalopoulosAChatzigeorgiouAPrapasSKamperEFAlterations in biomarkers of endothelial function following on-pump coronary artery revascularizationJ Clin Lab Anal201024638939821089169
   PubMed Web of Science ®Google Scholar
• GiaprezaLexi-Drugs Lexicomp Online [database online]Hudson, OHLexi-Comp, Inc2018 Available from: http://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/6582570Accessed March 26, 2018
   Google Scholar
• BusseLAGongTThompsonMOutcomes in patients with acute respiratory distress syndrome receiving angiotensin II for vasodilatory shockCritical Care201822Suppl 182
   Google Scholar